neuropathy semaglutide NAION Network Study Announcement Semaglutide doubles risk for nonarteritic

Oz calling it a revolutionary fat-busting drug

The 90-day check-in questionnaire is free

Activation of the GLP-1R has been demonstrated to upregulate the expression of forkhead box p3 protein, a transcription factor crucial for Treg function, thus fostering immune tolerance and mitigating autoreactive inflammation[22,23]

Smaller Biotechs and Collaborators: Companies like Zealand Pharma, Glycadia, and others have GLP-1 analogs or co-agonists in early trials, often in partnership with larger pharma (e.g., Novo Nordisk collaboration with Zealand)

While this can help with blood sugar control and weight loss, it can also lead to constipation or, in some cases, diarrhea

Hence, in contrast to rodent studies (4), GLP-1RAs may have little effect on human thyroid NETs